Bayer G4A Asset Manager Profile - aVenture Research
Bayer G4A is a global healthcare accelerator that focuses on investing in, mentoring, and scaling digital health solutions. Originally launched in Berlin in 2013 as Grants4Apps, the program has evolved to support startups and healthcare technology companies worldwide. Bayer G4A typically provides grants to early-stage companies, emphasizing innovations that drive health equity, access, and sustainability through digital health.
Notable portfolio companies include UE LifeSciences, which has raised $175,000. Bayer G4A is supported by a team of healthcare ecosystem experts and offers strategic partnership opportunities to help businesses grow. Their investment philosophy centers on leveraging behavioral science to develop impactful health solutions. The firm provides unique value-add services such as mentoring and extensive networking opportunities within the healthcare sector.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.